GLI Advantages and Consequences - SPANISH

Santiago C. Arce, Philip H. Quanjer, Sanja Stanojevic, Tim J. Cole, Janet Stocks

Source: Global Lung Function Initiative
Number: 0

PDF journal article, handout or slides

Rating: 5
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Santiago C. Arce, Philip H. Quanjer, Sanja Stanojevic, Tim J. Cole, Janet Stocks. GLI Advantages and Consequences - SPANISH. Global Lung Function Initiative

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
GLI Advantages and Consequences - ITALIAN
Source: Global Lung Function Initiative
Year: 2012

GLI Advantages and Consequences - DUTCH
Source: Global Lung Function Initiative
Year: 2012

GLI Advantages and Consequences
Source: Global Lung Function Initiative
Year: 2012

Late Breaking Abstract - Sensibility and specificity of the “SLEEP CLINICAL RECORD” Protocol  in Brazilian children.
Source: International Congress 2018 – New ideas about respiratory and sleep physiology in children
Year: 2018



LATE-BREAKING ABSTRACT: PRECLINICAL TESTING OF THERAPEUTIC WNT/beta-CATENIN ACTIVATION IN HUMAN 3D LUNG TISSUE CULTURES
Source: International Congress 2014 – Lung cell biology in injury and repair
Year: 2014

LATE-BREAKING ABSTRACT: ASSOCIATION OF SEVERE EXACERBATION WITH FEV1 DECLINE AND LOSS OF AIRWAY REVERSIBILITY IN ASTHMA
Source: International Congress 2014 – Asthma: still a heterogeneous condition!
Year: 2014


LATE-BREAKING ABSTRACT: GENE ENVIRONMENT INTERACTION ANALYSIS OF OBESITY AND ASTHMA
Source: International Congress 2014 – Genetics and environmental factors underlying asthma and COPD
Year: 2014

Late Breaking Abstract - PULMONARY REHABILITATION IN POST - COVID SUBJECTS WITH MODERATE LUNG RESTRICTION, A CASE SERIES.
Source: Virtual Congress 2021 – Pulmonary rehabilitation in clinical conditions
Year: 2021


Late Breaking Abstract - BENRALIZUMAB IN SEVERE ASTHMA: PRELIMINARY RESULTS FROM THE ITALIAN ANANKE STUDY
Source: Virtual Congress 2020 – Advances in asthma treatment
Year: 2020


Late Breaking Abstract - IMPACT OF CONFINEMENT ON ALS PATIENTS DUE TO THE SARS-CoV-2 PANDEMIC
Source: Virtual Congress 2020 – Pulmonary function and rehabilitation in non-respiratory disease
Year: 2020


LATE-BREAKING ABSTRACT: GENDER DIFFERENCES IN ASTHMATIC CHILDREN
Source: Annual Congress 2013 –Epidemiology of respiratory disease
Year: 2013

LATE-BREAKING ABSTRACT: THE FATE OF INHALED DRUG: CORTICOSTEROID PARTICLE SIZE EFFECTS IN ASTHMA
Source: Annual Congress 2013 –New physiologic boundaries
Year: 2013


LATE-BREAKING ABSTRACT: PERSISTENTLY HIGH EXHALED NITRIC OXIDE AND LUNG FUNCTION DECLINE IN PATIENTS WITH CONTROLLED ASTHMA AT BASELINE
Source: International Congress 2014 – Biomarkers of asthma control
Year: 2014


Late Breaking Abstract - A SINGLE-CENTER EXPERIENCE WITH HIGH-FLOW NASAL CANNULA FOR COVID-19 PATIENTS WITH ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS)
Source: Virtual Congress 2020 – Covering COVID - the best abstracts
Year: 2020




TORVAN VERSUS GAP: WHICH PERFORMS BETTER?
Source: Virtual Congress 2020 – Clinical aspects of idiopathic pulmonary fibrosis
Year: 2020


Late Breaking Abstract - SUPRAnav: A Clinical Trial Evaluating the Efficacy and Safety of a New Invention Device Designed for Continuous Supraglottic Aspiration in Mechanically Ventilated Patients.
Source: International Congress 2019 – ALERT: Abstracts Leading to Evolution in Respiratory Medicine Trials: Intensive care and infection
Year: 2019



Late Breaking Abstract - Does The High Use Of Oral Antiasthmatics Contribute To The Elevated Burden Of Asthma In India?
Source: International Congress 2019 – Blood eosinophils and more in airway diseases
Year: 2019




Late Breaking Abstract - Comparative Effectiveness of Anti-IL5/5R Versus Anti-IgE in Patients Eligible for Both (FIRE)
Source: Virtual Congress 2021 – Severe asthma: evaluation using patient-reported outcome measures (PROMs) and biomarkers, comorbidities and treatments
Year: 2021


Problems of Importance in Severe Asthma: A Patient Perspective
Source: International Congress 2019 – Person-centred approaches to COPD and asthma care
Year: 2019